Search results for: 'CHINA pharmaceutical market'

21 Mar 2025  |  Global  |  Market Research

Pharmaceutical Clinical Contract Peripheral Services, Global, 2025–2030

The CRO Industry is Witnessing Transformational Growth Due to Industry Convergence and an Increasing Reliance on the Functional Service Provider (FSP) Model

Infographics

×

As trial volumes normalize after the COVID-19 pandemic, pharma and biopharma companies are re-focusing on their drug development pipelines. As a result, the market has been creating an increasing number of clinical trial outsourcing opportunities for CROs, with these service providers also refining their processes to ensure better clinical trial tu...

The objective of this Strategic Analysis Service is to equip the C-level and senior exceutives of global healthcare and life sciences companies with cutting edge research, strategic planning, and structured advisory services. The Strategic Analysis of World Pediatric Pharmaceuticals Market provides insight into the present challenges and growth opp...

Pharmaceutical drug discovery and development suffers from declining success rates with new molecules, and the rate of return has shrunk from 16% in 2011 to almost 11% in 2018. Frost & Sullivan finds that traditional solutions focused primarily on data from limited sources and rule-based computational techniques used to address the understanding of...

A mass spectrometer (MS) determines atom/molecule mass by measuring the mass-to-charge ratio of its ions. It consists of four basic components: a sample inlet, an ionization source, a mass analyzer, and a detector. It is largely used in University research laboratories and government research institutions; pharmaceutical, biotechnology/biopharmaceu...

Organ-on-a-chip technology involves the incorporation of microphysiological systems harboring dynamic living 3D organoids, tissue-culture, or cell cultures on a microfluidic platform. The physiologically relevant Organ-chip models offer a better and more precise insight to the possible in vivo effects of drugs in the human body. The flexibility of ...

28 Aug 2020  |  Global  |  Technology Research

Data Science Impacting the Pharmaceutical Industry

Part I: Drug Discovery Applications

Infographics

×

Data science and AI have the potential to transform drug discovery in terms of costs, speed and efficiency. With explosion in biomedical data, data sharing and analysis platforms have surged. AI technologies are moving to the next phase of advancements, and when combined with other emerging tech areas, AI is expected to witness a full fledged adopt...

The impressive advances in life sciences research and development (R&D) befallen in the past two-three years are playing a leading role in the transformation of the healthcare industry. A myriad of new developments in the fields of gene and cell therapies, empowered with nanotechnology advances, omics technologies and novel smart molecules approach...

The research provides technological advances and insights across non-opioid pharmaceuticals for the management of pain. Key application areas explored in the research include neuropathic pain, migrane, post-surgical pain, cancer pain, chronic pain and migraine. The research encompasses technological advances across Nav1.7 inhibitors, Calcitonin Gen...

14 Jun 2021  |  Global  |  Market Research

China Belt and Road Initiative Growth Opportunities

CBRI to Ensure the Construction of Record-breaking Rail Routes, the Transformational Growth of Smart Cities, Smart Ports, Smart Highways, IoT and Cloud-enabled Smart Logistics Services, and the Proliferation of Mega Trucks and Mega Ships

Infographics

×

In 2013, China initiated the China Belt and Road Initiative (CBRI) to connect Asia, Europe, and Africa through a series of land and sea routes which would ensure greater connectivity and promote commerce between China and the rest of the world. China has aggressively promoted this endeavor that seeks to reestablish a series of trade routes similar ...